Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial) King Faisal Specialist Hospital & Research Centere Ongoing PLASMA DERIVED Factor VIII Recombinant FVIII 4 ABB- 09 -001 King Faisal Specialist Hospital and Research Center (Riyadh)
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study Eli Lilly Ongoing N/A 4 F3Z-MC-B010 Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Taif) , King Fahad Medical City (Riyadh)
An international, multicenter, observational study to compare real life VTE prophylaxis, during hospital stay, in cancer patients undergoing major abdominal or pelvic surgery versus international guidelines (ACCP 2008). Sanofi Ongoing N/A 4 DIREG_R_04917 King Faisal Specialist Hospital and Research Center (Jeddah)
Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi Sanofi Ongoing Lantus® 4 LANTUL06939 King Fahd Military Medical Complex (Dhahran), Armed Forces Hospital (Southern Region), Polyclinics in western province
Disease pattern in patient with acute respiratory tract infections in Saudi Arabia Sanofi Ongoing N/A 4 DIREG_L_05605 Erfan & Bagedo General Hospital (Jeddah)
National, observational, cross sectional survey evaluating the atrial fibrillation management and cardiovascular risk profile of AF patient. Sanofi Ongoing N/A 4 DIREG_L_05290 King Khalid University Hospital (Riyadh)
Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled Sanofi Ongoing Lantus® 4 Lantu_C_02762 King Abdulaziz University Hospital (Jeddah), King Fahad University Hospital (Al-Khobar)
Registry in the management of Acute Diarrhea in Children : Observational study in Daily practice Sanofi Ongoing N/A 4 DIREG_R_06373 King Fahad Medical City (Riyadh)
International Diabetes Management Practice Study - IDMPS Sanofi Ongoing N/A 4 DIREG_R_05168 King Fahad Hospital (Jeddah)
Unmet needs in allergic rhinitis: International Survey on Mangment of Allergic Rhinitis by Physician and Patient. Sanofi Ongoing N/A 4 DIREG_R_06411 Soliman Fakeeh Hospital (Jeddah)
View 671 - 680 From 756